Gavazzi, Gaëtan
Drevet, Sabine
Debray, Matthieu
Bosson, Jean Luc
Tidadini, Fatah
Paccalin, Marc
de Wazieres, Benoit
Celarier, Thomas
Bonnefoy, Marc
Vitrat, Virginie
Funding for this research was provided by:
Thermo Fisher Scientific
Programme Hospitalier de Recherche Clinique, French Ministry of Health
bioMérieux
Article History
Received: 9 August 2022
Accepted: 28 November 2022
First Online: 14 December 2022
Change Date: 30 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12877-023-03818-0
Declarations
:
: PROPAGE was conducted in compliance with the International Conference on Harmonisation-Good Clinical Practice Guidelines and the applicable regulatory requirements. The protocol was authorised by the Agence Nationale de Sécurité du Médicament on 19 September 2011 and approved by the <i>Comité de Protection des Personnes Sud Est V</i> (Independent Ethics Committee) of the teaching hospital of Grenoble on 05 October 2011 (approval n°2011-A01026-35). Written informed consent for participation in the study was obtained from all candidates or from their legal representatives.
: Not applicable.
: GG has received consulting fees from Thermo Fischer Scientific. Other co-authors report no conflicts of interest relevant to this article.